Published price vs quote-only
Wellorithm vs Maximus: Which One Publishes Its Price? (2026)
Wellorithm or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Wellorithm and Maximus side by side and the marketing reads almost identically. The programs underneath do not.
One of these programs can be evaluated before you start it and one cannot. Maximus lists $132.99/mo; with Wellorithm, pricing is not published; you receive a quote only after completing the intake quiz.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Maximus — $132.99/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most predictable bill
- Maximus — Flat rate at every dose, so titration does not change what you are charged.
- Fastest route to a first shipment
- Wellorithm — 2-minute eligibility quiz, then medication shipped to your home.
- Easiest to pay for
- Wellorithm — Neither publishes financing; both expect the full amount monthly.
Wellorithm vs Maximus: the specification
The rows below are the ones that differ enough between these two to be worth your attention.
| Wellorithm | Maximus | |
|---|---|---|
| Advertised price | Priced after the eligibility quiz | $132.99/mo |
| Rate after promotions | not published before intake | $133/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Price transparency | Quote only, after intake | Published upfront |
| Membership fee | Not stated | None |
| How fast you start | 2-minute eligibility quiz | Telemedicine intake, no clinic visits |
| State coverage | All 50 states | Not published |
| Tirzepatide | Not published | Not published |
| Patient reviews | 3,240 | 2,896 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
What Wellorithm and Maximus actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. Here is what each one costs across a realistic course of treatment, on published pricing.
| Wellorithm | Maximus | |
|---|---|---|
| First month | Not published | $133 |
| Months 2 onward | Not published | $133/mo |
| 6-month total | Not computable | $798 |
| 12-month total | Not computable | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
With Maximus the arithmetic is available in advance — $132.99/mo, on flat rate at every dose terms — so it can be compared against anything else on the market.
Wellorithm runs the other way around — pricing is not published; you receive a quote only after completing the intake quiz. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
Treat Wellorithm's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
Wellorithm in detail
The pitch is licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin. Take the 2-Minute Quiz to Check Your Eligibility
You start with 2-minute eligibility quiz; medication arrives via medication shipped to your home. The price behaves as quoted only after intake.
On the clinical side, virtual consultations with licensed clinicians, prescribing compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Strong fit for patients in states with limited GLP-1 telehealth access
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- Both compounded semaglutide and tirzepatide available
- Fully virtual consultations with medication shipped to your home
Wellorithm cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Pricing is not published, you only get a quote after completing the intake quiz
- Smaller, less-established platform with limited public reviews
Where it gives ground to Maximus: a smaller platform with no published price and limited public review volume.
Maximus: what you are buying
$132.99 per Month
The process is telemedicine intake, no clinic visits, then home delivery. On money, expect flat rate at every dose — published upfront.
Behind the prescription sits prescriptions approved by licensed doctors, filled through U.S. pharmacies. Available medication: compounded semaglutide.
Maximus pros
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
- Prescriptions approved by licensed doctors
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
Set beside Wellorithm, the thing to weigh: the smallest patient base here, with limited published detail on tirzepatide.
Who should choose Wellorithm, and who should choose Maximus
Choose Wellorithm if:
- you want to start on their timeline: 2-minute eligibility quiz
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- you would get real value from licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin
- you are in a state where GLP-1 telehealth coverage is patchy
Choose Maximus if:
- you want the price you sign up at to survive titration
- you want the full price in front of you before completing an intake
- what it leads on is worth paying for in your case: a low flat rate with a simple direct-pay structure and nothing bolted on
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
Honest trade-offs
On price. Only Maximus publishes a rate you can plan against ($132.99/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. Wellorithm provides virtual consultations with licensed clinicians. Maximus provides prescriptions approved by licensed doctors, filled through U.S. pharmacies. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Wellorithm covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
Evidence and regulatory status
Neither Wellorithm nor Maximus manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.
Wellorithm vs Maximus: common questions
How much does Wellorithm cost?
Pricing is not published; you receive a quote only after completing the intake quiz. That is the honest answer, and it is the main practical drawback next to Maximus, which publishes $132.99/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which is cheaper to start, Wellorithm or Maximus?
Only Maximus publishes a first-month figure ($132.99/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
Do Wellorithm or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Wellorithm or Maximus?
Wellorithm, with 3,240 against 2,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Wellorithm compared with Maximus?
Wellorithm advertises 2-minute eligibility quiz, with medication shipped to your home. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are Wellorithm and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Wellorithm operates on quoted only after intake with pricing quote only, after intake, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin; Maximus leads on a low flat rate with a simple direct-pay structure and nothing bolted on.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Wellorithm vs He & She MDPublished price vs quote-only
- Wellorithm vs TMatesPublished price vs quote-only
- Mochi Health vs MaximusLocked price vs escalating price
- Elevate Health vs MaximusTirzepatide access
- Directmeds vs EmbodyPublished price vs quote-only
- Directmeds vs Sprout HealthPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellorithm or Maximus, and does not sell treatment. Read our ranking methodology.